New PET tracer could reveal hidden immune cells in lung tumors
NCT ID NCT05933239
First seen Jun 02, 2026 · Last updated Jun 10, 2026 · Updated 1 time
Summary
This study tests a new imaging agent (68GaNOTA-anti-MMR-VHH2) that may help doctors see certain immune cells called macrophages in lung cancer tumors using a PET scan. About 20 adults with non-small cell lung cancer who are scheduled for surgery will receive the agent before their operation. The goal is to see if the scan matches what is found in the removed tumor tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universitair Ziekenhuis Brussel
RECRUITINGJette, Brussels Capital, 1090, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.